<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01738568</url>
  </required_header>
  <id_info>
    <org_study_id>12-003357</org_study_id>
    <nct_id>NCT01738568</nct_id>
  </id_info>
  <brief_title>Effects of Aging and Aerobic Exercise Training on Brain Glucose Metabolism</brief_title>
  <official_title>Effect of Aging and Aerobic Exercise Training on Brain Glucose Metabolism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aging is associated with a loss of brain function and conditions such as dementia and&#xD;
      Alzheimer's disease. It is likely that decreased brain metabolism is contributing to the&#xD;
      progression of age related degenerative diseases. Aerobic exercise training can increase&#xD;
      brain volumes and is associated with decreased risk for degenerative brain conditions.&#xD;
      However, little is know about the changes that occur to brain metabolism with aerobic&#xD;
      training and aging.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Actual">February 12, 2015</completion_date>
  <primary_completion_date type="Actual">February 12, 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Brain Glucose Uptake</measure>
    <time_frame>12 weeks</time_frame>
    <description>The investigators will assess brain glucose uptake using positron emission tomography at baseline and following 12-weeks of either aerobic exercise training or sedentary control period.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">27</enrollment>
  <condition>Dementia</condition>
  <arm_group>
    <arm_group_label>Exercise</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Aerobic exercise</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>High intensity aerobic training</intervention_name>
    <description>High intensity aerobic interval training will be performed 12-weeks. Exercise training will last 1 hour per day, 5 days per week and include high intensity interval cycling at ~70-95% maximum workload for 4 minutes followed by 3 minutes of rest.</description>
    <arm_group_label>Exercise</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Sedentary Control</intervention_name>
    <description>Sedentary control participants will not perform any regular exercise for 12-weeks.</description>
    <arm_group_label>Exercise</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Healthy sedentary adults aged 18-30 or 65-80 years of all ethnicities will be eligible.&#xD;
        Pregnant women, children, prisoners or other at risk populations will not be recruited.&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18-30 years or 65-80 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Body mass index (BMI) &gt;31 kg/m2&#xD;
&#xD;
          -  Smoking&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Participation in structured exercise (&gt;2 times per week for 30 minutes or longer)&#xD;
&#xD;
          -  Cardiovascular, metabolic (type 2 diabetes, fasting plasma glucose at or above 110&#xD;
             mg/dL and untreated hypo- or hyperthyroidism) or renal disease&#xD;
&#xD;
          -  Orthopedic problems that would keep them from being able to ride an exercise bicycle,&#xD;
             lift weights or do a combination of these exercise&#xD;
&#xD;
          -  Medications that are known to impact on mitochondrial function: Corticosteroids,&#xD;
             opiates, benzodiazepines, tricyclic antidepressants, beta blockers, sulfonylureas,&#xD;
             insulin, anticoagulants, barbiturates, insulin sensitizers, fibrates (PPAR gamma&#xD;
             agonist)&#xD;
&#xD;
          -  Claustrophobia&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Val Lowe, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic in Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>November 27, 2012</study_first_submitted>
  <study_first_submitted_qc>November 29, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 30, 2012</study_first_posted>
  <last_update_submitted>August 24, 2021</last_update_submitted>
  <last_update_submitted_qc>August 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Val Lowe</investigator_full_name>
    <investigator_title>PI</investigator_title>
  </responsible_party>
  <keyword>High intensity aerobic training</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dementia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

